This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
TenTweetNephJC on X. Natriuresis guidance for intensification of diuretics is one strategy to PUSH decongestion in patient’s with acute heart failure.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) October 5, 2023
Adequate decongestion to prevent rehospitalization & excess mortality are the goals when treating HF. So, why do we fail so often?
This week we look at natriuresis guided diuretic therapy in hospitalized HF patients.
✳️10 tweets #NephJC catch-up ✳️ pic.twitter.com/PjDKcscTOV
Does natriuresis-guided diuretic therapy in patients with acute heart failure improve clinical outcomes?
NSMC Intern Sameen Aamer answers it with a VA
